Plain-English translation of NCT03975322 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is testing a new way to predict which white patches in the mouth (called oral leukoplakia) are likely to turn into cancer. Right now, doctors use a microscope to look at the appearance of these patches, but this method isn't always accurate. Researchers want to see if a new test based on immune system markers can better predict which patches need treatment and which ones can be safely watched.
White patches in the mouth can sometimes turn into mouth cancer, but doctors cannot always tell which ones will. About 2% of these patches become cancer each year, but the current method of predicting this risk is unreliable and depends on who examines the tissue. A better prediction tool would help doctors avoid unnecessary surgery on low-risk patches while catching dangerous ones early.
You likely qualify if…
You likely don't qualify if…
If you join this study, researchers will collect a tissue sample from your mouth white patch (likely during a biopsy or examination). The sample will be tested using the new prediction method to see if it can better identify cancer risk. You will be asked to provide consent and may need follow-up visits so researchers can track whether your patch changes over time.
AI-generated summary from trial data · Aug 11, 2026 · Not medical advice
Germany
Enrollment target
~500 participants
Started
December 2019
Primary completion
December 2024
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 80 Years
Last updated on clinicaltrials.gov in December 2019.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Manuel Weber, MD, DMD
Maxillofacial Surgery Erlangen
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.